ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO483

Patient Perspectives on Incremental Peritoneal Dialysis: A National Survey

Session Information

  • Home Dialysis - 2
    October 26, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 802 Dialysis: Home Dialysis and Peritoneal Dialysis

Authors

  • Perl, Jeffrey, St Michael's Hospital, Toronto, Ontario, Canada
  • Dhoot, Arti, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
  • Spigler, Michael, American Kidney Fund, Rockville, Maryland, United States
  • Robinson, Bruce M., University of Michigan, Ann Arbor, Michigan, United States
Background

Incremental peritoneal dialysis (PD) may improve quality of life, reduce therapy burden and ease transition to PD. Incremental approaches for automated PD (APD) include: less than 7 days a week, carrying no daytime dwell, reduced dwell volumes or less time on the cycler. For CAPD, decreasing the exchange frequency or reducing dwell volumes are also strategies. We sought to understand patient preferences for various strategies via the dissemination of a national survey to individuals on PD.

Methods

A pilot tested, anonymous, voluntary survey was administered in Aug-Sep 2023. The American Kidney Fund (AKF) distributed the survey via an online link to those receiving charitable assistance from AKF, social media platform, and AKF’s monthly newsletter. The survey was for those over 18 years, on PD now or in the past year, and the goal was “to learn about ways that PD can help patients have a good quality of life”. Descriptive results were analyzed.

Results

Of the 564 respondents, 9.6% were aged 18- 39 years, 75.9% between 40-69 years and 23.8% over 70 years with 59.1% females, 62.5% Caucasian, and 15.5% identifying as black. PD was initiated <1 year in 35.1% of patients. Within 6 months of PD-start, 70.6% of patients reported performing PD treatment 7 days a week. Patients ranked various initial preferred PD prescriptions between 1-4, with 1 as most important as shown in figure 1. Less days of PD treatment per week consistently emerged with the highest priority rankings (ranging from 48- 61.2%) among those receiving APD versus reducing to a single daily dwell for CAPD (42.7%).

Conclusion

Patients value less days of PD treatment per week or a single daily exchange over other approaches to incremental PD. Days off from PD as a strategy is currently underutilized in most patients at time of PD initiation. Further research should evaluate the safety and feasibility of providing these prescription variations in select incident individuals.